Deborah Budge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Deborah Budge has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
Rami Alharethi
Cardiology, Intermountain Medical Center, Salt Lake City, UT, USA
18 shared publications- Abdallah G. Kfoury
Intermountain Heart Institute, Heart Failure & Transplant, Salt Lake City, UT, USA
12 shared publications - Kismet Rasmusson
Heart Failure Prevention and Treatment Program, Intermountain Medical Center, Salt Lake City, UT
12 shared publications - Jennifer L. Nixon
Heart Failure and Transplant Program, Intermountain Heart Institute, Salt Lake City, UT
8 shared publications Josef Stehlik
8 shared publicationsAbdallah Kfoury
6 shared publications
Latest Publications
- 6 February 2016
- Published by Wiley in Clinical Transplantation
- Vol. 30 (3) , 195-201
Reasons for, and outcomes of patients who were referred for a ventricular assist device but were declined: the recent era forgotten ones
Ventricular assist devices (VADs) have a proven survival benefit in select patients with advanced heart failure, yet many patients considered for implantation are declined for various reasons. The outcome of these patients is obscure owing to their exclusion from recent VAD studies. We aim to compare the outcomes of patients who received a VAD to those who did not. For this study, the Artificial Heart Program's database at Intermountain Medical Center was queried from 2006 to 2012 for patients referred for a VAD. Kaplan-Meier survival analysis was performed with log-rank test determining significance. Of 232 patients included, 118 patients received a VAD and 114 patients did not. The prevailing reason for VAD decline in eligible and willing patients was due to pre-existing illness (39%). Mortality was higher in non-VAD vs. VAD patients (58.8% vs. 35.6%, p < 0.001) with a median time-to-death of 67 (IQR:12-314) and 301 (IQR:136-694) d, respectively (p = 0.007). In the current era of non-pulsatile VADs, mortality of patients who are considered but not implanted remains high. Additionally, mortality of these patients occurred much sooner. Educational efforts ensuring timely referral for VAD therapy are important to maximize the number of patients who may benefit.
- 6 February 2016
- Published by Wiley in Clinical Transplantation
- Vol. 30 (3) , 195-201
Reasons for, and outcomes of patients who were referred for a ventricular assist device but were declined: the recent era forgotten ones
Ventricular assist devices (VADs) have a proven survival benefit in select patients with advanced heart failure, yet many patients considered for implantation are declined for various reasons. The outcome of these patients is obscure owing to their exclusion from recent VAD studies. We aim to compare the outcomes of patients who received a VAD to those who did not. For this study, the Artificial Heart Program's database at Intermountain Medical Center was queried from 2006 to 2012 for patients referred for a VAD. Kaplan-Meier survival analysis was performed with log-rank test determining significance. Of 232 patients included, 118 patients received a VAD and 114 patients did not. The prevailing reason for VAD decline in eligible and willing patients was due to pre-existing illness (39%). Mortality was higher in non-VAD vs. VAD patients (58.8% vs. 35.6%, p < 0.001) with a median time-to-death of 67 (IQR:12-314) and 301 (IQR:136-694) d, respectively (p = 0.007). In the current era of non-pulsatile VADs, mortality of patients who are considered but not implanted remains high. Additionally, mortality of these patients occurred much sooner. Educational efforts ensuring timely referral for VAD therapy are important to maximize the number of patients who may benefit.
- 1 August 2015
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 21 (8) , S127-S128
Peripartum Cardiomyopathy Network: Medication and Device Therapy Use in the First Year
- 1 August 2015
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 21 (8) , S127-S128
Peripartum Cardiomyopathy Network: Medication and Device Therapy Use in the First Year
- 13 September 2014
- Published by Springer Nature in Current Transplantation Reports
- Vol. 1 (4) , 246-256
Antibody-mediated Rejection in Heart Transplantation
- 13 September 2014
- Published by Springer Nature in Current Transplantation Reports
- Vol. 1 (4) , 246-256
Antibody-mediated Rejection in Heart Transplantation
- 1 August 2014
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 20 (8) , S64
Discrete-Event Simulation (DES) to Evaluate and Improve the Performance of an Advanced Heart Failure/Transplant Clinic: A Real-Life Experience
- 1 August 2014
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 20 (8) , S64
Discrete-Event Simulation (DES) to Evaluate and Improve the Performance of an Advanced Heart Failure/Transplant Clinic: A Real-Life Experience
- 1 August 2014
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 20 (8) , S12-S13
Learning from Heart Failure Patients to Improve Patient Centered Care
- 1 August 2014
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 20 (8) , S12-S13
Learning from Heart Failure Patients to Improve Patient Centered Care
- 1 August 2014
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 20 (8) , S8
Late Antibody-Mediated Rejection (AMR) in Heart Transplantation: How “Late” Is It?
- 1 August 2014
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 20 (8) , S8
Late Antibody-Mediated Rejection (AMR) in Heart Transplantation: How “Late” Is It?
- 31 August 2013
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 19 (8) , S5
A Predictive Model of Heart Failure Readmissions: Results of a Multivariate Analysis
- 31 August 2013
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 19 (8) , S5
A Predictive Model of Heart Failure Readmissions: Results of a Multivariate Analysis
- 31 August 2013
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 19 (8) , S80-S81
Is 30-Day Readmission a Valid Measure for Quality Care or Simply an Indicator of Severe Disease in Patients Discharged after Heart Failure Hospitalization?
- 31 August 2013
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 19 (8) , S80-S81
Is 30-Day Readmission a Valid Measure for Quality Care or Simply an Indicator of Severe Disease in Patients Discharged after Heart Failure Hospitalization?
- 31 August 2013
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 19 (8) , S11
Regional Structural Uniformity of Left Ventricular Remodeling in Patients with Advanced Non Ischemic Cardiomyopathy
- 31 August 2013
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 19 (8) , S11
Regional Structural Uniformity of Left Ventricular Remodeling in Patients with Advanced Non Ischemic Cardiomyopathy
- 31 August 2013
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 19 (8) , S35-S36
A Heart Failure Readmission Analysis: Identifying Factors and Assessing Risk
- 31 August 2013
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 19 (8) , S35-S36
A Heart Failure Readmission Analysis: Identifying Factors and Assessing Risk